ATREON joins the Spring 2026 cohort of the Future of Health Grant - Level 3

We’re proud to share that ATREON has been selected as a Level 3 participant in the Spring 2026 cohort of the Future of Health Grant, among 352 applicants working to shape the future of healthcare.

This recognition reflects the progress we’ve made developing DETECTRA, ATREON’s solution designed to support follow-up in inflammatory arthritis.

With DETECTRA, patients can capture guided smartphone images of their hands and report symptoms from home. This provides clinicians with structured information between visits, helping support follow-up and preparation of consultations.

Contact us to learn more or to explore investment opportunities!